[Malaria in 2022: clinical and therapeutic aspects].

Le paludisme en 2022 : aspects cliniques et thérapeutiques.
Alphonse Laveran Description Malaria Method Plasmodium falciparum Resistance Treatment

Journal

Medecine tropicale et sante internationale
ISSN: 2778-2034
Titre abrégé: Med Trop Sante Int
Pays: France
ID NLM: 9918227363206676

Informations de publication

Date de publication:
30 06 2023
Historique:
received: 09 01 2023
accepted: 17 01 2023
medline: 2 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: epublish

Résumé

In 2022 as in 1884, the clinical presentation of uncomplicated malaria is unspecific: fever of variable intensity, continuous or rhythmic, chills, flu syndrome, headache, respiratory and digestive disorders. At any time, it can evolve into a severe form (ex-pernicious attack or cerebral malaria) or even lethal. By reading again Alphonse Laveran's book on malarial fevers, we realized to what extent the observations made at that time allowed for a methodical and orderly description of the clinical forms of malaria, very close to what we can still observe today. No symptom or sign is pathognomonic of the disease. Only the detection of plasmodia or "malaria microbes" by direct or immuno-chromatographic methods allows for diagnostic confirmation, which is a prerequisite for the implementation of a curative treatment.Serendipity, synthetic chemistry and traditional medicine are the three methods that led to the discovery and large-scale production of antimalarial drugs. Serendipity for quinine, synthetic chemistry for chloroquine, and research conducted around traditional Chinese medicine for artemisinin and its derivatives. The latter have marked a real revolution in the management of malaria, both in its uncomplicated and severe forms. However, as with other antimalarial drugs, its medium- and long-term efficacy is compromised by the emergence and spread of resistance in malaria parasites, particularly

Identifiants

pubmed: 37525671
doi: 10.48327/mtsi.v3i2.2023.378
pmc: PMC10387310
pii:
doi:

Substances chimiques

Antimalarials 0
Quinine A7V27PHC7A
Chloroquine 886U3H6UFF

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 SFMTSI.

Références

Med Sci (Paris). 2016 Jan;32(1):106-9
pubmed: 26850615
Ann Intensive Care. 2020 Feb 12;10(1):21
pubmed: 32052207
Int J Parasitol Drugs Drug Resist. 2021 Apr;15:43-56
pubmed: 33556786
Travel Med Infect Dis. 2021 Nov-Dec;44:102177
pubmed: 34687871
Parasitol Res. 2012 Jul;111(1):1-6
pubmed: 22411634
Lancet Infect Dis. 2022 May;22(5):586-587
pubmed: 35460650
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
Lancet Infect Dis. 2021 Oct;21(10):1395-1406
pubmed: 34111412
Lancet. 2005 Aug 27-Sep 2;366(9487):717-25
pubmed: 16125588
Lancet Infect Dis. 2022 Jun;22(6):867-878
pubmed: 35276064

Auteurs

Cécile Ficko (C)

Service de maladies infectieuses et tropicales, Hôpital d'instruction des armées Bégin, 69 avenue de Paris, 94160 Saint-Mandé, France.
École du Val-de-Grâce, Paris, France.

Pierre-Louis Conan (PL)

Service de maladies infectieuses et tropicales, Hôpital d'instruction des armées Bégin, 69 avenue de Paris, 94160 Saint-Mandé, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH